Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
This study is currently recruiting participants.
Verified September 2012
by Region Skane
Study NCT01458600 Information provided by Region Skane
First Received on October 19, 2011. Last Updated on September 6, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graves´ Disease
Additional conditions recognized in this trial
Eye Diseases
Graves Disease
Graves Ophthalmopathy
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Exophthalmos
Eye Diseases, Hereditary
Goiter
Hyperthyroidism
Immune System Diseases
Orbital Diseases
Thyroid Diseases
Interventions listed in this trial
Diclofenac
Methimazole
L-thyroxin
Propranolol
Metoprolol
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents, Non-Steroidal
Metoprolol succinate
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Antihypertensive Agents
Antirheumatic Agents
Antithyroid Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Mikael Lantz
Back to top of Main Content
